Top 5 Most Profitable Pharmaceutical Companies In The World

3. Moderna Inc. (NASDAQ:MRNA)

2022 Net Income: $8.36 billion

2022 Revenue: $19.3 billion  

Driven by sales of its COVID-19 vaccine, Spikevax, Moderna Inc. (NASDAQ:MRNA) achieved the 19th position among the top pharmaceutical companies in 2022. However, the company faces uncertainty in future sales due to declining vaccination demand. While Moderna has secured $5 billion in business for 2023, a revenue target for the year has yet to be projected.

While future COVID vaccine sales should become more predictable, Moderna Inc. (NASDAQ:MRNA) is investing $4.5 billion in research and development. It is also developing vaccines for respiratory syncytial virus and flu and collaborating with Merck & Co. on a personalized therapeutic cancer vaccine.